Institution
Ochsner Medical Center
Healthcare•New Orleans, Louisiana, United States•
About: Ochsner Medical Center is a healthcare organization based out in New Orleans, Louisiana, United States. It is known for research contribution in the topics: Population & Medicine. The organization has 980 authors who have published 1159 publications receiving 49961 citations. The organization is also known as: Ochsner Hospital & Ochsner Foundation Hospital.
Papers published on a yearly basis
Papers
More filters
TL;DR: A special focus is on MIF-1 (prolyl-leucyl-glycinamide) that was discovered in the Kastin laboratory and shown effective to treat human depression with greater efficacy and faster onset of action than traditional antidepressants at the time of clinical trial.
2 citations
TL;DR: Restaging MRI could not predict ypT and ypN stage and there was a trend for longer DFS and OS in patients with low-intermediate mNAR scores compared to patients with high mN AR scores.
2 citations
TL;DR: The Society for Cardiovascular Angiography and Interventions (SCAI) publications committee concisely summarized and provided editorial commentary on the most important trials from recent, large international meetings.
Abstract: With the plethora of clinical trials, it is difficult for busy interventional cardiologists to stay up to date. Therefore, the Society for Cardiovascular Angiography and Interventions (SCAI) publications committee concisely summarized and provided editorial commentary on the most important trials from recent, large international meetings. The intent is to provide this summary every six months to allow quick assimilation of trial results into interventional practice.
2 citations
TL;DR: On-site volumetric assessment of donors provides useful information for the planning of an in situ split and for selection of recipients, and may expand the donor pool to recipients previously felt to be unsuitable due to donor and/or recipient weight.
2 citations
TL;DR: Current evidence does not demonstrate sufficiently large benefit of heparin-bonded polytetrafluoroethylene for dialysis access to justify higher cost, and the trial was stopped for futility.
2 citations
Authors
Showing all 993 results
| Name | H-index | Papers | Citations |
|---|---|---|---|
| Carl J. Lavie | 106 | 1135 | 49318 |
| Michael R. Jaff | 82 | 442 | 28891 |
| Michael F. O'Rourke | 81 | 451 | 35355 |
| Mandeep R. Mehra | 80 | 644 | 31939 |
| Richard V. Milani | 80 | 454 | 23410 |
| Christopher J. White | 77 | 621 | 25767 |
| Bruce A. Reitz | 74 | 333 | 18457 |
| Robert C. Bourge | 69 | 273 | 24397 |
| Sana M. Al-Khatib | 69 | 377 | 17370 |
| Hector O. Ventura | 66 | 478 | 16379 |
| Andrew Mason | 63 | 360 | 15198 |
| Aaron S. Dumont | 60 | 386 | 13020 |
| Philip J. Kadowitz | 55 | 379 | 11951 |
| David W. Dunn | 54 | 195 | 8999 |
| Lydia A. Bazzano | 51 | 267 | 13581 |